NZ608560A - Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions - Google Patents

Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions

Info

Publication number
NZ608560A
NZ608560A NZ608560A NZ60856006A NZ608560A NZ 608560 A NZ608560 A NZ 608560A NZ 608560 A NZ608560 A NZ 608560A NZ 60856006 A NZ60856006 A NZ 60856006A NZ 608560 A NZ608560 A NZ 608560A
Authority
NZ
New Zealand
Prior art keywords
administering
compositions
methods
growth factor
nerve growth
Prior art date
Application number
NZ608560A
Inventor
Arnon Rosenthal
David L Shelton
Patricia Ann Walicke
Original Assignee
Rinat Neuroscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/104,248 external-priority patent/US7569364B2/en
Application filed by Rinat Neuroscience Corp filed Critical Rinat Neuroscience Corp
Publication of NZ608560A publication Critical patent/NZ608560A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Discloses the use of an effective amount of anti-NGF antibody in the preparation or manufacture of a medicament for the treatment to improve physical function in an individual having osteoarthritis.
NZ608560A 2005-04-11 2006-04-11 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions NZ608560A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/104,248 US7569364B2 (en) 2002-12-24 2005-04-11 Anti-NGF antibodies and methods using same
NZ59533606 2006-04-11

Publications (1)

Publication Number Publication Date
NZ608560A true NZ608560A (en) 2015-05-29

Family

ID=53490938

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ608560A NZ608560A (en) 2005-04-11 2006-04-11 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions

Country Status (1)

Country Link
NZ (1) NZ608560A (en)

Similar Documents

Publication Publication Date Title
IL239170A0 (en) Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same
TW200513468A (en) Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors
EA201290189A1 (en) HUMAN NEUTRALIZING ANTI-NGF ANTIBODIES AS SELECTIVE INHIBITORS OF METABOLIC WAYS OF NERVES GROWTH FACTOR
WO2011014255A8 (en) Treatment of crohn's disease with laquinimod
MY155961A (en) Chemical compounds 251
TW200806299A (en) Treatment of pain
EA201300116A1 (en) ACTIVIN-ACTRIIA ANTAGONISTS AND APPLICATION TO STIMULATE BONE GROWTH IN CANCER PATIENTS
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
TW200639159A (en) Treatment of pain
SG166093A1 (en) Inhibitors of brutonæs tyrosine kinase
TW200606162A (en) Pyrazolopyridine derivatives
MX2007004955A (en) Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally.
EA200971107A1 (en) CATECHOLAMINE DERIVATIVES, USEFUL FOR THE TREATMENT OF PARKINSON'S Disease
DE502005005636D1 (en) Spirocyclische cyclohexan-derivate
MX2013012661A (en) Bicyclic pyridazine compounds as pim inhibitors.
MX2009009133A (en) Improved medicinal compositions comprising buprenorphine and naloxone.
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
SE0400184D0 (en) New therapeutic use
RU2013132566A (en) THERAPEUTIC AGAINST HERNIASIS
MX366496B (en) Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use.
TNSN08506A1 (en) Substituted carboxamides
DE602004016950D1 (en) USE OF CYCLIN D1 INGREDIENTS FOR BREAST CANCER TREATMENT
MX2008015323A (en) Pharmaceutical composition comprising cyclobenzaprine and aceclofenac in association.
NZ608560A (en) Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions
WO2007144889A3 (en) Treatment of neurofibromatosis

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 6 YEARS UNTIL 11 APR 2016 BY SHELSTON IP

Effective date: 20150902

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2017 BY THOMSON REUTERS

Effective date: 20160317

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2018 BY THOMSON REUTERS

Effective date: 20170322

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2019 BY THOMSON REUTERS

Effective date: 20180321

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2020 BY THOMSON REUTERS

Effective date: 20190319

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2021 BY THOMSON REUTERS

Effective date: 20200317

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2022 BY THOMSON REUTERS

Effective date: 20210310

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 11 APR 2023 BY THOMSON REUTERS

Effective date: 20220308

LAPS Patent lapsed